Exalenz Bioscience LTD.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Union NJ United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2008
NCT00825630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

EXALENZ BIOSCIENCE | Exalenz Bioscience LTD.